Today’s volatile political environment is creating uncertainty and worry that can disrupt sleep and may even lead to a sleep ...

Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today ...

Daridorexant, a dual orexin receptor antagonist, is currently approved for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

New research suggests certain sleep patterns can help predict whether comatose patients will regain consciousness.

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic ...

Overnight bursts of brain waves seen in normal sleep can help doctors predict which unresponsive patients hospitalized with acute severe brain injuries will awaken and eventually recover. Several ...

Among patients with OSA, sleep surgery vs CPAP therapy or no treatment reduces the risk for motor vehicle accidents.

Patients with primary open-angle glaucoma were found to have lower blood flow to the eye during sleep, which may contribute ...

Fragmented sleep is associated with the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD).

Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.